NCT01868451 2025-07-09Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin LymphomaMemorial Sloan Kettering Cancer CenterPhase NA Active not recruiting118 enrolled